Tradestie Institutional Equity Comparison Engine

PASW vs OPTO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PASW Overall Edge

PASW Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ping An Biomedical Co., Ltd. Ordinary Shares (PASW) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, PASW trades at N/M Forward P/E with -41.3% operating margin (-47.4% YoY revenue) versus OPTO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PASW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OPTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PASW N/M vs OPTO N/M Fwd P/E
Growth & Margin Winner PASW
Op Margin -41.3% vs N/A ยท YoY -47.4% vs N/A
Momentum & Technical Winner PASW
1Y +95.7% vs -53.6% ยท 52W Pos 17% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PASW NASDAQ
Ping An Biomedical Co., Ltd. Ordinary Shares
Institutional Equity
$1.13
-10.32% 1D
Market Cap $3.6M
1M Return +743.28%
1Y Return +95.67%
Forward P/E N/M
Unified AI Score
59.1 / 100 HOLD
Tech 60.0 Fund 47.0 Flow 50.0 Mom 60.0
OPTO US Equity
OPTO
Institutional Equity
$12.11
-12.53% 1D
Market Cap N/A
1M Return -31.8%
1Y Return -53.57%
Forward P/E N/M
Unified AI Score
47.3 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PASW +95.67% OPTO -53.57% Spread: +879.8 pp (PASW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PASW TTM Op. Margin: -41.3% OPTO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASW vs OPTO. Trailing 12-month operating profitability (PASW -41.3% vs OPTO N/A) and valuation multiples (PASW N/M vs OPTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PASW (7) vs OPTO (1)
Institutional Metric PASW OPTO Criterion Row Winner
Market Capitalization Scale $3.6M N/A Larger Scale PASW
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -47.4% N/A Higher Growth PASW
Operating Margin (TTM) Profitability -41.3% N/A Higher Margin PASW
Net Profit Margin Profitability -14.8% N/A Higher Margin PASW
Return on Equity (ROE) Capital Efficiency -11.3% N/A Higher ROE PASW
52-Week Range Position Momentum 17% ($0โ€“$6) 0% ($12โ€“$26) Stronger Trend PASW
Beta / 30D Volatility Risk Regime -10.07ฮฒ ยท 11691% Vol 3.64ฮฒ ยท 108% Vol Lower Realized Risk OPTO
Unified Institutional Score Composite Signal 59.1 / 100 (HOLD) 47.3 / 100 (HOLD) Higher Composite PASW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PASW vs OPTO Buy Guide
PASW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PASW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OPTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OPTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PASW nor OPTO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.